Transient ST elevation and ventricular fibrillation during PCI

Transient ST-segment elevation during percutaneous coronary intervention (PCI) can be brief, yet it may herald a malignant ventricular arrhythmia. The pattern matters because sudden ventricular fibrillation can interrupt a procedure while coronary flow is still vulnerable, creating a narrow window for defibrillation and revascularisation. A patient who develops VF may therefore provide the earliest evidence of an acute coronary occlusion, even when the initial ECG has already normalised.

VF during PCI is a time-critical emergency, not simply a complication to be managed after the procedure. Electrical instability may reflect acute ischaemia, transient coronary occlusion, spasm, catheter-related injury, or a substrate made vulnerable by infarction and electrolyte disturbance. The immediate goal is to restore organised circulation, while the team identifies and treats the coronary cause without losing sight of other reversible precipitants.

Management must combine a rehearsed adult advanced life support pathway with immediate access to coronary angiography. Continuous ECG monitoring, frequent blood-pressure checks, ready access to resuscitation equipment and a shared mental model of who defibrillates, who manages the airway and who activates coronary rescue are essential.

Recognising the electrical warning

When ST elevation appears during balloon inflation, stent deployment or contrast injection, the coronary circulation should be assessed immediately rather than accepted as a benign transient. The tracing may resolve quickly, but resolution does not establish that the myocardium is safe. Obtain a 12-lead ECG, compare it with pre-procedure recordings, document the timing of the change and ask whether chest pain, hypotension, bradycardia or ventricular ectopy accompanies it. Persistent ST elevation after PCI suggests failed reperfusion and requires an immediate response. Clinicians can compare institutional experience with the journal’s current clinical articles.

VF can precede diagnostic ST elevation, follow several minutes of ischaemia, or occur during reperfusion. If the patient loses consciousness without a pulse, the monitor rhythm determines the next action: VF or pulseless ventricular tachycardia is treated with an immediate shock, followed by high-quality CPR. In Australian hospitals, this should follow ANZCOR-aligned basic and advanced life support protocols and local defibrillator policy. Calling 000, mobilising the cardiac arrest team and stopping the procedure occur in parallel; a prolonged search for the cause must not delay defibrillation.

Mechanisms that link ischaemia to fibrillation

Plaque rupture or erosion can produce an acute coronary thrombus that intermittently obstructs flow. Spontaneous reperfusion may then create only transient ST elevation, while the injured myocardium remains electrically unstable. A transient occlusion can also trigger VF through conduction-system ischaemia, abnormal automaticity or heterogeneous conduction. The angiogram may reveal a culprit lesion with unstable flow, an occlusive thrombus, or a culprit vessel that has already reopened.

Coronary vasospasm is another important mechanism. Epicardial spasm during PCI may respond to intracoronary nitrates, whereas microvascular spasm can cause ST elevation without a fixed obstructive lesion. Catheter-induced dissection, distal embolisation, wire trauma, air contamination and acute stent thrombosis should each be considered according to the sequence of events. Distinguishing these causes matters because treatment ranges from aspiration or stenting to vasodilators and correction of an equipment-related problem.

Reperfusion itself can be arrhythmogenic. Abrupt restoration of flow after a prolonged occlusion may cause myocardial stunning, inflammatory and autonomic changes, and oxygen free-radical injury, increasing the risk of VF even when the ST segments settle. Background factors can lower the threshold: previous myocardial infarction, left ventricular dysfunction, diabetes, long QT or other inherited arrhythmia syndromes, digoxin toxicity, and potassium or magnesium abnormalities. These factors rarely act alone, so angiography, laboratory results and the procedural record should be interpreted together.

Managing ventricular fibrillation in the cath lab

The first priority is defibrillation. Resume CPR immediately after each shock, use oxygenated ventilation and continuous compressions, and cycle through rhythm checks and shocks without unnecessary interruption. IV access, arterial access, airway support and a clearly assigned team leader should proceed concurrently. Once defibrillation attempts are underway, amiodarone or lidocaine may be used according to the local advanced life support protocol. Magnesium is appropriate for torsades de pointes or documented hypomagnesaemia, not as a routine substitute for shock. Avoid unnecessary catecholamine surges and search for hypoxia, acidosis, hyperkalaemia and myocardial ischaemia.

At the same time, ask whether VF is the first presentation of acute coronary syndrome. Aspirin and anticoagulation should be considered when appropriate, with antiplatelet therapy tailored to the planned intervention and bleeding risk. Urgent coronary angiography can identify a thrombotic culprit lesion, spasm, dissection, embolism or stent thrombosis. PCI with aspiration or stenting may be required for a flow-limiting culprit, while intracoronary vasodilators and observation may be appropriate for spasm. Persistent ischaemia, instability or recurrent VF should prompt immediate action rather than a delayed diagnostic work-up.

After circulation returns, transfer care to a capable intensive care environment and continue post-arrest assessment. Serial ECGs, troponins, electrolytes, echocardiography and review of angiographic images help define the substrate. Temporary mechanical circulatory support may be needed in selected patients with cardiogenic shock, while recurrent VF requires correction of residual ischaemia and metabolic abnormalities. Documentation should record the exact rhythm, shock energies, drugs, procedural events, coronary findings and recurrence, because these details determine both immediate treatment and later risk assessment.

Defining the cause and reducing recurrence

A survivor of VF after PCI needs a structured diagnosis, not just a discharge summary stating “VF during procedure”. Determine whether the event occurred before, during or after coronary occlusion; whether ST elevation resolved spontaneously; and whether a fixed culprit lesion, spasm, dissection, embolism or no obstructive disease was found. Review continuous ECG recordings, haemodynamic trends, contrast exposure and the sequence of catheter movements. Assess left ventricular function and arrhythmic substrate with appropriate imaging and, when indicated, electrophysiology input.

Long-term management follows the demonstrated cause. Persistent acute coronary syndrome or coronary scar may require guideline-based medical therapy, appropriate antiplatelet duration, cardiac rehabilitation and discussion of implantable cardioverter-defibrillator protection when the risk of sudden death remains high and the event was not fully reversible. When rate or rhythm control is later considered, coexisting lung disease should not automatically drive treatment choice; a companion beta-blocker safety review is useful for examining that evidence. Correcting electrolyte abnormalities, reviewing QT-prolonging medicines and assessing recurrent syncope complete the risk assessment.

Readiness across Australian catheterisation laboratories

Australia’s geography shapes the response. Around-the-clock PCI services are concentrated in metropolitan centres such as Sydney, Melbourne, Brisbane and Perth, while regional and remote hospitals may depend on aeromedical retrieval or transfer. A sudden arrest can magnify every delay in obtaining a second operator, resuscitation drugs or definitive coronary care. Hospitals should therefore agree in advance on transfer criteria, cath-lab activation procedures and how a receiving team is contacted when the first team is managing VF.

Everyday Australian systems already provide useful foundations. Calling 000 remains the standard emergency route, and 112 also works from mobile phones. Automated external defibrillators are familiar in airports, shopping centres, sporting clubs and many workplaces, so public-access defibrillation can precede ambulance arrival. Public hospitals provide much of Australia’s emergency cardiac care within the Medicare system, while private hospitals and catheterisation services may stabilise and transfer complex cases. The Therapeutic Goods Administration regulates relevant devices and medicines, but hospitals still need local governance, consumable availability and regular team simulation.

Emergency treatment should not be delayed for consent or paperwork. State and territory law generally supports care for a patient facing immediate danger, while federal and state health-records rules govern documentation and sharing, including the My Health Record Act 2012. Clear recording of arrest treatment and PCI findings supports safe transfers, communication with primary care and future research. Review each VF and transfer checklist this month, rehearse a catheterisation-lab arrest with the full team, and route eligible cases to the journal through its submission guidance. Share what the local drill exposes, because standardised Australian data can turn a rare procedural emergency into safer systems of care.